Xiao-Jun Li
Overview
Explore the profile of Xiao-Jun Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
268
Citations
3547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Jiao S, Wang J, Wu R, Zhang T, Wang C, et al.
Anaerobe
. 2025 Feb;
92:102948.
PMID: 40015666
Three bacterial strains, namely HSP-334, HSP-342 and HSP-536, were isolated from human oral dental biofilm. These strains were identified as Gram stain-negative, straight or slightly curved anaerobes. Based on 16S...
2.
Zhang Y, Zhang Y, Jen Y, Wang Y, Li X
Cureus
. 2025 Feb;
17(2):e79069.
PMID: 39958400
Curative-intent radiotherapy for multiple lung metastases with more than 10 lesions is limited by lung dose constraints and respiratory motion. Carbon ion radiotherapy (CIRT) leverages the Bragg peak for precision...
3.
Yan Q, Li X, Wang Q, Jia W, Wang S
Mol Neurobiol
. 2025 Jan;
PMID: 39789238
Approaches of promoting a neural milieu permissive for plasticity and resilience against neuronal injury are important strategies for the treatment of a range of neurological disorders. Fibroblast growth factor 21...
4.
Lin X, Yang P, Li X, Xu Z, Wu H, Hu S, et al.
Oncol Lett
. 2024 Dec;
29(2):76.
PMID: 39650229
The present study aimed to investigate the inhibitory effect of luteoloside on the proliferation, migration and invasion of gastric cancer (GC) cells based on network pharmacology and experiments. GC-associated targets...
5.
Li X, Shan Q, Wu X, Miao H, Zhao Y
Cell Mol Life Sci
. 2024 Dec;
81(1):480.
PMID: 39636415
Gut microbiota is a complex and dynamic system that plays critical roles in human health and various disease. Progressive chronic kidney disease (CKD) suggests that patients irreversibly progress to end-stage...
6.
He Z, Glass M, Venkatesan P, Feser M, Lazaro L, Okada L, et al.
bioRxiv
. 2024 Nov;
PMID: 39554042
Some autoimmune diseases, including rheumatoid arthritis (RA), are preceded by a critical subclinical phase of disease activity. Proactive clinical management is hampered by a lack of biological understanding of this...
7.
Li T, Liang W, Zhao Y, Chen W, Zhu H, Duan Y, et al.
Front Immunol
. 2024 Nov;
15:1390589.
PMID: 39534602
Introduction: Psoriasis, a persistent skin condition caused by the disorder of the immune system, impacts approximately 1.25 million individuals globally. Nevertheless, the presence of adverse effects in conventional clinical drugs...
8.
Huang Y, Yang G, Chen H, Li X, Wu Y, Zhang K, et al.
World J Gastrointest Oncol
. 2024 Oct;
16(9):3887-3897.
PMID: 39350993
Background: Immunochemotherapy involving the combination of programmed cell death 1/programmed cell death ligand 1 inhibitors with chemotherapy has advanced the treatment of locally advanced esophageal squamous cell carcinoma (ESCC). The...
9.
Gong Q, Sharma M, Kuan E, Glass M, Chander A, Singh M, et al.
bioRxiv
. 2024 Sep;
PMID: 39314416
The generation and maintenance of protective immunity is a dynamic interplay between host and environment that is impacted by age. Understanding fundamental changes in the healthy immune system that occur...
10.
Wang Y, Li X, Wang W, Zou L, Miao H, Zhao Y
Phytother Res
. 2024 Sep;
38(11):5441-5457.
PMID: 39289784
Renal fibrosis is an outcome of chronic kidney disease, independent of the underlying etiology. Renal fibrosis is caused primarily by oxidative stress and inflammation. We identified the components of Plantaginis...